{"transactions":[{"id":44467,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-01T22:50:17.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":20634,"price":178.99,"value":3693279.66,"ownership":{"direct":true},"balance_after":107267,"source":{"system":"sec-edgar","filing":"0001415889-24-006158","document":"form4-03012024_050307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006158/form4-03012024_050307.xml","form_type":"4"}},{"id":45442,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Option (Right to Buy)","published_at":"2024-02-20T22:15:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":18912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,304 on February 15, 2025, 6,304 on February 15, 2026, and 6,304 on February 15, 2027."}],"balance_after":18912,"derivative":{"exercise_price":0,"exercise_date":"2025-02-15","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":18912},"source":{"system":"sec-edgar","filing":"0001415889-24-004418","document":"form4-02202024_050219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/form4-02202024_050219.xml","form_type":"4"}},{"id":45441,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":5348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":127901,"source":{"system":"sec-edgar","filing":"0001415889-24-004418","document":"form4-02202024_050219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/form4-02202024_050219.xml","form_type":"4"}},{"id":45440,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":5350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":122553,"source":{"system":"sec-edgar","filing":"0001415889-24-004418","document":"form4-02202024_050219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/form4-02202024_050219.xml","form_type":"4"}},{"id":45439,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":7552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":117203,"source":{"system":"sec-edgar","filing":"0001415889-24-004418","document":"form4-02202024_050219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/form4-02202024_050219.xml","form_type":"4"}},{"id":45438,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CSO, GLOBAL RESEARCH"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":28322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":109651,"source":{"system":"sec-edgar","filing":"0001415889-24-004418","document":"form4-02202024_050219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/form4-02202024_050219.xml","form_type":"4"}},{"id":57882,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-02T21:35:29.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":27922,"price":154.28,"value":4307806.16,"ownership":{"direct":true},"balance_after":81329,"source":{"system":"sec-edgar","filing":"0001415889-23-003844","document":"form4-03022023_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003844/form4-03022023_040301.xml","form_type":"4"}},{"id":58482,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Option (Right to Buy)","published_at":"2023-02-21T23:07:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":20256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,752 on February 16, 2024, 6,752 on February 16, 2025, and 6,752 on February 16, 2026."}],"balance_after":20256,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":20256},"source":{"system":"sec-edgar","filing":"0001415889-23-002940","document":"form4-02212023_110258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/form4-02212023_110258.xml","form_type":"4"}},{"id":58481,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:07:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":5350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":109251,"source":{"system":"sec-edgar","filing":"0001415889-23-002940","document":"form4-02212023_110258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/form4-02212023_110258.xml","form_type":"4"}},{"id":58480,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:07:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":7552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":103901,"source":{"system":"sec-edgar","filing":"0001415889-23-002940","document":"form4-02212023_110258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/form4-02212023_110258.xml","form_type":"4"}},{"id":58479,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:07:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":9481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":96349,"source":{"system":"sec-edgar","filing":"0001415889-23-002940","document":"form4-02212023_110258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/form4-02212023_110258.xml","form_type":"4"}},{"id":58478,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D AND CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:07:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":40640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":86868,"source":{"system":"sec-edgar","filing":"0001415889-23-002940","document":"form4-02212023_110258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/form4-02212023_110258.xml","form_type":"4"}},{"id":69858,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:09:51.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":13408,"price":149.54,"value":2005032.32,"ownership":{"direct":true},"balance_after":46228,"source":{"system":"sec-edgar","filing":"0001179110-22-001835","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001835/edgar.xml","form_type":"4"}},{"id":70255,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Option (Right to Buy)","published_at":"2022-02-22T22:33:49.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":25394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 8,465 on February 17, 2023, 8,465 on February 17, 2024, and 8,465 on February 17, 2025."}],"balance_after":25394,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":25394},"source":{"system":"sec-edgar","filing":"0001179110-22-001509","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/edgar.xml","form_type":"4"}},{"id":70254,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:33:49.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":6609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":59636,"source":{"system":"sec-edgar","filing":"0001179110-22-001509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/edgar.xml","form_type":"4"}},{"id":70253,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:33:49.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":9483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":53027,"source":{"system":"sec-edgar","filing":"0001179110-22-001509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/edgar.xml","form_type":"4"}},{"id":70252,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:33:49.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":2530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":43544,"source":{"system":"sec-edgar","filing":"0001179110-22-001509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/edgar.xml","form_type":"4"}},{"id":70251,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:33:49.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":11642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":41014,"source":{"system":"sec-edgar","filing":"0001179110-22-001509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/edgar.xml","form_type":"4"}},{"id":92090,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:29:15.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":7740,"price":107.74,"value":833907.6,"ownership":{"direct":true},"balance_after":29372,"source":{"system":"sec-edgar","filing":"0001179110-21-002599","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002599/edgar.xml","form_type":"4"}},{"id":92766,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Option(right to buy)","published_at":"2021-02-22T23:17:46.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":37267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,423  on February 18, 2022 12,422  on February 18, 2023, and 12,422 on February 18, 2024."}],"balance_after":37267,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common stock","underlying_shares":37267},"source":{"system":"sec-edgar","filing":"0001179110-21-002045","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/edgar.xml","form_type":"4"}},{"id":92765,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:17:46.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":9483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":37112,"source":{"system":"sec-edgar","filing":"0001179110-21-002045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/edgar.xml","form_type":"4"}},{"id":92764,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:17:46.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":2530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":27629,"source":{"system":"sec-edgar","filing":"0001179110-21-002045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/edgar.xml","form_type":"4"}},{"id":92763,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:17:46.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":1240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":25099,"source":{"system":"sec-edgar","filing":"0001179110-21-002045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/edgar.xml","form_type":"4"}},{"id":92762,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:17:46.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":4216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":23859,"source":{"system":"sec-edgar","filing":"0001179110-21-002045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/edgar.xml","form_type":"4"}},{"id":106573,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-03T21:54:23.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":5477,"price":85.42,"value":467845.34,"ownership":{"direct":true},"balance_after":19643,"source":{"system":"sec-edgar","filing":"0001179110-20-002856","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002856/edgar.xml","form_type":"4"}},{"id":107150,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Option (right to buy)","published_at":"2020-02-24T23:02:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":62193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,731 on February 20, 2021, 20,731 on February 20, 2022, and 20,731 on February 20, 2023."}],"balance_after":62193,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":62193},"source":{"system":"sec-edgar","filing":"0001179110-20-002134","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002134/edgar.xml","form_type":"4"}},{"id":107149,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:02:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":2532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":25120,"source":{"system":"sec-edgar","filing":"0001179110-20-002134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002134/edgar.xml","form_type":"4"}},{"id":107148,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:02:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":1239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":22588,"source":{"system":"sec-edgar","filing":"0001179110-20-002134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002134/edgar.xml","form_type":"4"}},{"id":107147,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:02:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":2280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":21349,"source":{"system":"sec-edgar","filing":"0001179110-20-002134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002134/edgar.xml","form_type":"4"}},{"id":107146,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11433,"kind":"person","name":"Hudson Thomas J","position":1,"cik":"0001781947","reported_name":"Hudson Thomas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:02:11.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":6321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":19069,"source":{"system":"sec-edgar","filing":"0001179110-20-002134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002134/edgar.xml","form_type":"4"}}]}